Redalpine: Investment Portfolio & Startup News
Redalpine
To add a bio or update investment portfolio click update information.
Investment Portfolio


Basecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models
Basecamp Research trains biological foundation models, called EDEN, on a proprietary genomic dataset spanning more than 30 countries. The models are used to design therapeutics, starting with in vivo cell therapies that reprogram a patient's cells inside the body to treat conditions such as cancer and autoimmune disease.


Apoha unlocks £27m in funding led by Singular to measure how molecules and materials behave under real-world conditions
Apoha has built a platform that measures how molecules, formulations and materials behave under real-world conditions, generating a new class of empirical data it calls Liquid State Intelligence. Its first product, VIBE, takes a microscopic sample, applies controlled stresses in liquid, and captures the resulting wave patterns as more than 1,000 behavioural descriptors - used by pharma, food and materials companies to predict product performance before costly late-stage failure.


Helical raises a £7.5m seed round led by redalpine to build virtual labs for pharma research
Helical is a virtual lab platform that enables pharmaceutical scientists to test biological hypotheses computationally before running physical experiments. It provides a shared system for biologists and machine learning engineers to run, validate and reproduce discovery workflows.


9fin secures £130m Series C led by HarbourVest to build clearer view of debt markets
9fin is a data and analytics platform for debt capital markets. It provides real-time information and tools to help credit professionals analyse markets, track developments, and make decisions.


Synthesized raises £15m Series A led by Redalpine to automate the most difficult parts of testing with agentic AI
Synthesized provides agentic AI infrastructure for software testing, automating the creation of realistic, compliant test data and environments so regulated organisations can test and release software faster and more safely.


DaltonTx launches with £4m seed round from Redalpine, IQ Capital and Seedcamp to build the intelligence backbone of drug discovery
DaltonTx builds an adaptive AI platform for drug discovery that integrates directly into scientific workflows, helping research teams analyse data, design molecules and make decisions across small molecule and biologic programmes.


Magdrive raises £8m seed funding led by Redalpine for its next-generation spacecraft propulsion system
Magdrive develops high-thrust electric propulsion systems for satellites using solid metal propellants, enabling more efficient manoeuvring, longer missions and future in-space servicing and manufacturing.


9fin raises £40m Series B led by Highland Europe to build next generation of debt capital markets technology
9fin provides AI powered analytics and research tools for debt capital markets, giving professionals faster access to intelligence across leveraged loans, high yield bonds, private credit and distressed debt.


ExpressionEdits raises £10m seed round to advance protein expression using AI-driven intronisation technology
ExpressionEdits develops an AI-driven gene design platform that improves protein expression by redesigning genes with introns, helping researchers and manufacturers produce therapeutic proteins that are difficult to express using existing methods.
More venture news
- 17 Nov 2026

Isomorphic LabsIsomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI
Series CLife Sciences - 11 Nov 2026

FractileFractile raises a £540m Series C from investors including Thrive and Founders Fund to build the chips that AI frontiers run on
Series CDeep Tech - 15 Oct 2026

OMass TherapeuticsOMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
Series CLife Sciences